“The reduction in guidance is primarily due to revenue uncertainty related to projects the firm has been working on for the National Health Service division of the U.K. government,” Morningstar said in a recent note on the Computer Sciences. “The company missed a key milestone for the NHS project, which has led to a delay in the payment.”
Rydex S&P Equal Weight Technology (NYSEArca: RYT) slipped fractionally Thursday.
Rydex S&P Equal Weight Technology
